Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases

Advances in Experimental Medicine and Biology

Volumn 990, Issue , 2013, Pages 61-86

  Guipaud, Olivier ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

Bioindicator; Biomarker; Diagnostic; Ionizing radiation; Irradiation; Normal tissue toxicity; Omics; Plasma; Prognostic; Proteome; Proteomics; Radiation exposure; Radiotherapy; Serum

Indexed keywords

ALBUMIN; AMYLASE; BIOLOGICAL MARKER; CITRULLINE; CYTOKINE; FIBRINOGEN; FLT3 LIGAND; HAPTOGLOBIN; IMMUNOGLOBULIN; LIPOPROTEIN; PLASMA PROTEIN; PROTEOME; TRANSCRIPTOME; TRANSFERRIN; TRYPSIN INHIBITOR;

ARTICLE; GASTROINTESTINAL TOXICITY; GENOME; HUMAN; IONIZING RADIATION; LIVER INJURY; LUNG TOXICITY; MASS SPECTROMETRY; METABOLOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; RADIATION EXPOSURE; RADIATION SICKNESS; RADIOBIOLOGY; SKIN INJURY; TWO DIMENSIONAL ELECTROPHORESIS; UROGENITAL TRACT DISEASE; ANIMAL; BLOOD; ENVIRONMENTAL EXPOSURE; METABOLOMICS; METHODOLOGY; MULTIVARIATE ANALYSIS; RADIATION INJURY; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; ENVIRONMENTAL EXPOSURE; HUMANS; MASS SPECTROMETRY; METABOLOMICS; MULTIVARIATE ANALYSIS; PROTEOME; PROTEOMICS; RADIATION INJURIES; RADIATION, IONIZING;

MLCS; MLOWN;

EID: 84934435364     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-5896-4_4     Document Type: Article

References (114)

1. Stone HB, McBride WH, Coleman CN (2002) Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, 6-8 Sept 2000. Radiat Res 157:204-223
2. Stone HB, Coleman CN, Anscher MS et al (2003) Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4:529-536
3. Rubin P, Johnston CJ, Williams JP et al (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99-109
4. Hong JH, Chiang CS, Tsao CY et al (1999) Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol 75:1421-1427
5. Haston CK, Zhou X, Gumbiner-Russo L et al (2002) Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 62:3782-3788
6. Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61: 223-231
7. Gorin NC, Fliedner TM, Gourmelon P et al (2006) Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol 85: 671-679
8. Friesecke I, Beyrer K, Fliedner TM (2001) How to cope with radiation accidents: the medical management. Br J Radiol 74:121-122
9. Fliedner TM, Friesecke I, Beyrer K (2001) Medical management of radiation accident: manual on the acute radiation syndrome. METREPOL (European Commission Concerted Action). The British Institute of Radiology, Oxford
10. Shrieve DC, Loeffler JS (2011) Human radiation injury. Lippincott Williams & Wilkins, Philadelphia
11. Steel GG (2001) The case against apoptosis. Acta Oncol 40:968-975
12. Valerie K, Yacoub A, Hagan MP et al (2007) Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 6:789-801
13. Fu XL, Huang H, Bentel G et al (2001) Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50:899-908
14. Chen Y, Rubin P, Williams J et al (2001) Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49:641-648
15. Chen Y, Williams J, Ding I et al (2002) Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26-33
16. Fajardo LF, Berthrong M (1988) Vascular lesions following radiation. Pathol Annu 23:297-330
17. Paris F, Fuks Z, Kang A et al (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297
18. Hauer-Jensen M, Kong FM, Fink LM et al (1999) Circulating thrombomodulin during radiation therapy of lung cancer. Radiat Oncol Investig 7:238-242
19. Barcellos-Hoff MH (1998) How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res 150:S109-S120
20. Brush J, Lipnick SL, Phillips T et al (2007) Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 17:121-130
21. Fajardo LF (2005) The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44:13-22
22. Rodemann HP, Bamberg M (1995) Cellular basis of radiation-induced fibrosis. Radiother Oncol 35:83-90
23. Corthals GL, Wasinger VC, Hochstrasser DF et al (2000) The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21:1104-1115
24. Hu S, Loo JA, Wong DT (2006) Human body fluid proteome analysis. Proteomics 6:6326-6353
25. Sharma M, Halligan BD, Wakim BT et al (2008) The urine proteome as a biomarker of radiation injury. Proteomics Clin Appl 2:1065-1086
26. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
27. Thadikkaran L, Siegenthaler MA, Crettaz D et al (2005) Recent advances in blood-related proteomics. Proteomics 5:3019-3034
28. Lundblad RL (2005) Considerations for the use of blood plasma and serum for proteomic analysis. Internet J Genomics Proteomics 1:1-12
29. Misek DE, Kuick R, Wang H et al (2005) A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 5:3343-3352
30. Omenn GS, States DJ, Adamski M et al (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publiclyavailable database. Proteomics 5:3226-3245
31. Tammen H, Schulte I, Hess R et al (2005) Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5: 3414-3422
32. Bjorhall K, Miliotis T, Davidsson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307-317
33. Fountoulakis M, Juranville JF, Jiang L et al (2004) Depletion of the high-abundance plasma proteins. Amino Acids 27:249-259
34. Fujii K, Nakano T, Kawamura T et al (2004) Multidimensional protein profiling technology and its application to human plasma proteome. J Proteome Res 3:712-718
35. Wang YY, Cheng P, Chan DW (2003) A simple affinity spin tube filter method for removing high-abundant common proteins or enriching lowabundant biomarkers for serum proteomic analysis. Proteomics 3:243-248
36. Anderson NL, Polanski M, Pieper R et al (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3:311-326
37. Rose K, Bougueleret L, Baussant T et al (2004) Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 4:2125-2150
38. Farrah T, Deutsch EW, Omenn GS et al (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 10(M110):006353
39. Deutsch EW, Eng JK, Zhang H et al (2005) Human plasma PeptideAtlas. Proteomics 5:3497-3500
40. Tirumalai RS, Chan KC, Prieto DA et al (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2: 1096-1103
41. Hu L, Ye M, Zou H (2009) Recent advances in mass spectrometry-based peptidome analysis. Expert Rev Proteomics 6:433-447
42. Geho DH, Liotta LA, Petricoin EF et al (2006) The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol 10:50-55
43. Mehta AI, Ross S, Lowenthal MS et al (2003) Biomarker amplification by serum carrier protein binding. Dis Markers 19:1-10
44. Tian Y, Zhang H (2010) Glycoproteomics and clinical applications. Proteomics Clin Appl 4:124-132
45. Arnold JN, Saldova R, Galligan MC et al (2011) Novel glycan biomarkers for the detection of lung cancer. J Proteome Res 10:1755-1764
46. Arnold JN, Saldova R, Hamid UM et al (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8:3284-3293
47. Bones J, Byrne JC, O'Donoghue N et al (2011) Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J Proteome Res 10:1246-1265
48. Kyselova Z, Mechref Y, Al Bataineh MM et al (2007) Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6:1822-1832
49. Morelle W, Michalski JC (2007) Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2:1585-1602
50. Pabst M, Altmann F (2011) Glycan analysis by modern instrumental methods. Proteomics 11: 631-643
51. Petricoin EF, Ardekani AM, Hitt BA et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577
52. Petricoin EF, Zoon KC, Kohn EC et al (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1:683-695
53. Pieper R, Gatlin CL, Makusky AJ et al (2003) The human serum proteome: display of nearly 3700 chromatographically separated protein spots on twodimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3:1345-1364
54. Cho SY, Lee EY, Lee JS et al (2005) Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 5:3386-3396
55. Martosella J, Zolotarjova N, Liu H et al (2005) Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 4:1522-1537
56. Qin S, Ferdinand AS, Richie JP et al (2005) Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins. Proteomics 5:3183-3192
57. Tang HY, Ali-Khan N, Echan LA et al (2005) A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 5:3329-3342
58. Wasinger VC, Locke VL, Raftery MJ et al (2005) Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma. Proteomics 5:3397-3401
59. Horn A, Kreusch S, Bublitz R et al (2006) Multidimensional proteomics of human serum using parallel chromatography of native constituents and microplate technology. Proteomics 6:559-570
60. Sheng S, Chen D, Van Eyk JE (2006) Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics 5:26-34
61. Nolan JP, Mandy FF (2001) Suspension array technology: new tools for gene and protein analysis. Cell Mol Biol (Noisy-le-Grand) 47:1241-1256
62. Nolan JP, Mandy F (2006) Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems. Cytometry A 69:318-325
63. Haab BB (2005) Antibody arrays in cancer research. Mol Cell Proteomics 4:377-383
64. Haab BB (2003) Methods and applications of antibody microarrays in cancer research. Proteomics 3:2116-2122
65. Chen S, Haab BB (2009) Analysis of glycans on serum proteins using antibody microarrays. Methods Mol Biol 520:39-58
66. Ray S, Reddy PJ, Jain R et al (2011) Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 11:2139-2161
67. Gao WM, Kuick R, Orchekowski RP et al (2005) Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 5:110
68. Miller JC, Zhou H, Kwekel J et al (2003) Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3:56-63
69. Orchekowski R, Hamelinck D, Li L et al (2005) Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res 65:11193-11202
70. Sun Z, Fu X, Zhang L et al (2004) A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection. Anticancer Res 24:1159-1165
71. Anderson L (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 563:23-60
72. LaBaer J (2005) So, you want to look for biomarkers (introduction to the special biomarkers issue). J Proteome Res 4:1053-1059
73. Landers KA, Burger MJ, Tebay MA et al (2005) Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer 114:950-956
74. Barrett A, Jacobs A, Kohn J et al (1982) Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed) 285:170-171
75. Becciolini A, Giannardi G, Cionini L et al (1984) Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands. Acta Radiol Oncol 23:9-14
76. Bertho JM, Demarquay C, Frick J et al (2001) Level of Flt3-ligand in plasma: a possible new bioindicator for radiation-induced aplasia. Int J Radiat Biol 77:703-712
77. Lutgens LC, Deutz NE, Gueulette J et al (2003) Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys 57:1067-1074
78. Guipaud O, Benderitter M (2009) Protein biomarkers for radiation exposure: towards a proteomic approach as a new investigation tool. Ann Ist Super Sanita 45:278-286
79. Hong JH, Chiang CS, Campbell IL et al (1995) Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33: 619-626
80. Magic Z, Matic-Ivanovic S, Savic J et al (1995) Ionizing radiation-induced expression of the genes associated with the acute response to injury in the rat. Radiat Res 143:187-193
81. Trutic N, Magic Z, Urosevic N et al (2002) Acutephase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy. Comp Biochem Physiol C Toxicol Pharmacol 133:461-470
82. Chen C, Lorimore SA, Evans CA et al (2005) A proteomic analysis of murine bone marrow and its response to ionizing radiation. Proteomics 5:4254-4263
83. Cengiz M, Akbulut S, Atahan IL et al (2001) Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys 49:1093-1096
84. Guipaud O, Holler V, Buard V et al (2007) Timecourse analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics 7:3992-4002
85. Kong FM, Ten Haken RK, Schipper MJ et al (2005) High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: longterm results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63:324-333
86. Cai XW, Shedden K, Ao X et al (2010) Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 77:867-876
87. Cai XW, Shedden KA, Yuan SH et al (2011) Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer. J Thorac Oncol 6:1073-1078
88. Chung SI, Seong J, Park YN et al (2010) Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats. J Radiat Res (Tokyo) 51:643-650
89. Menard C, Johann D, Lowenthal Met al (2006) Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 66:1844-1850
90. Oh JH, Craft JM, Townsend R et al (2011) A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. J Proteome Res 10:1406-1415
91. Pevsner PH (2009) Biomarkers of ionizing radiation. US Patent 20,090,289,182
92. Pietrowska M, Polanska J, Walaszczyk A et al (2011) Association between plasma proteome profiles analysed by mass spectrometry, a lymphocytebased DNA-break repair assay and radiotherapyinduced acute mucosal reaction in head and neck cancer patients. Int J Radiat Biol 87:711-719
93. Rithidech KN, Honikel L, Rieger R et al (2009) Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays. Int J Radiat Biol 85:432-447
94. Spencer SJ, Bonnin DA, Deasy JO et al (2009) Bioinformatics methods for learning radiationinduced lung inflammation from heterogeneous retrospective and prospective data. J Biomed Biotechnol 2009: Article ID 892863
95. Widlak P, Pietrowska M, Wojtkiewicz K et al (2011) Radiation-related changes in serum proteome profiles detected by mass spectrometry in blood of patients treated with radiotherapy due to larynx cancer. J Radiat Res (Tokyo) 52:575-581
96. Ao X, Zhao L, Davis MA et al (2009) Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol 2:6
97. Christensen E, Pintilie M, Evans KR et al (2009) Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. Clin Cancer Res 15:5576-5583
98. Hart JP, Broadwater G, Rabbani Z et al (2005) Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 63:1448-1454
99. Kong FM, Ao X, Wang L et al (2008) The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy. Cancer Control 15:140-150
100. Partridge MA, Chai Y, Zhou H et al (2010) Highthroughput antibody-based assays to identify and quantify radiation-responsive protein biomarkers. Int J Radiat Biol 86:321-328
101. Rube CE, Palm J, Erren M et al (2008) Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3:e2898
102. Marchetti F, Coleman MA, Jones IM et al (2006) Candidate protein biodosimeters of human exposure to ionizing radiation. Int J Radiat Biol 82:605-639
103. Zhao L, Wang L, Ji W et al (2009) Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with nonsmall-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 74:1385-1390
104. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
105. Goltry KL, Epperly MW, Greenberger JS (1998) Induction of serum amyloid A inflammatory response genes in irradiated bone marrow cells. Radiat Res 149:570-578
106. Muller K, Meineke V (2007) Radiation-induced alterations in cytokine production by skin cells. Exp Hematol 35:96-104
107. Satoh T, Hosokawa M (1998) The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol 38:257-288
108. Lee WM, Galbraith RM (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326:1335-1341
109. Chen Y, Zhu J, Lum PY et al (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452:429-435
110. Andreyev HJ, Wotherspoon A, Denham JW et al (2010) Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 11:310-312
111. Andreyev HJ, Wotherspoon A, Denham JW et al (2011) "Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol 46: 389-397
112. Altshuler D, Daly MJ, Lander ES (2008) Genetic mapping in human disease. Science 322: 881-888
113. Schadt EE (2009) Molecular networks as sensors and drivers of common human diseases. Nature 461:218-223
114. Chaze T, Slomianny MC, Milliat F et al (2013). Alteration of the serum N-glycome of mice locally exposed to high doses of ionizing radiation. Mol Cell Proteomics. 2012 Nov 12. [Epub ahead of print].